Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1030240 | 1.00 | F10 (0.63) | F10 | |
| SCHEMBL12374765 | 0.89 | F10 (0.65) | F10 | |
| SCHEMBL1026919 | 0.89 | F10 (0.65) | F10 | |
| SCHEMBL8261774 | 0.86 | F10 (0.84) | F10 | |
| SCHEMBL1030154 | 0.86 | F10 (0.84) | F10 | |
| SCHEMBL4447429 | 0.84 | F10 (0.83) | F10 | |
| SCHEMBL1082257 | 0.82 | F10 (0.81) | F10 | |
| SCHEMBL2253925 | 0.82 | F10 (0.85) | F10 | |
| SCHEMBL1027621 | 0.82 | F10 (0.85) | F10 | |
| SCHEMBL2251421 | 0.82 | F10 (0.85) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195997-A1 | Dicarboxamide Derivatives | ZBINDEN KATRIN GROEBKE | 2011-08-11 | — | — | US | disclosed |
| WO-2007122104-A1 | DICARBOXAMIDE DERIVATIVES | F. HOFFMANN - LA ROCHE AG (CH) | 2007-11-01 | — | — | WO | disclosed |
| US-20070249683-A1 | Dicarboxamide derivatives | HOFFMANN-LA ROCHE INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249683-A1 | Dicarboxamide derivatives | HOFFMANN-LA ROCHE INC. | 2007-10-25 | — | — | US | disclosed |
| EP-1847537-A1 | Dicarboxamide derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195997-A1 | Dicarboxamide Derivatives | F12, F2, F3 | F10 9/4885 |
| US-20070249683-A1 | Dicarboxamide derivatives | F12, F2, F3 | F10 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.